Vision of Commercial Success: Investment and Partnering Landscape for Psychedelics

While psychedelic drugs have been historically stigmatized due to their use as recreational drugs, the commercialization of psychedelics and psychedelic-derived compounds for the treatment of psychiatric and neurological disorders has gained significant momentum over the last 5 years. Two events are seen as watershed moments for the surge of interest in psychedelics.